These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 20031564)

  • 1. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study.
    Ridker PM; Paré G; Parker AN; Zee RY; Miletich JP; Chasman DI
    Circ Cardiovasc Genet; 2009 Feb; 2(1):26-33. PubMed ID: 20031564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry.
    Ahmad T; Chasman DI; Buring JE; Lee IM; Ridker PM; Everett BM
    Circ Cardiovasc Genet; 2011 Feb; 4(1):74-80. PubMed ID: 21252145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.
    Schierer A; Been LF; Ralhan S; Wander GS; Aston CE; Sanghera DK
    Pharmacogenet Genomics; 2012 Feb; 22(2):95-104. PubMed ID: 22143414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels.
    Corsetti JP; Ryan D; Rainwater DL; Moss AJ; Zareba W; Sparks CE
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1657-64. PubMed ID: 20489166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis.
    Trinder M; Wang Y; Madsen CM; Ponomarev T; Bohunek L; Daisely BA; Julia Kong H; Blauw LL; Nordestgaard BG; Tybjærg-Hansen A; Wurfel MM; Russell JA; Walley KR; Rensen PCN; Boyd JH; Brunham LR
    Circulation; 2021 Mar; 143(9):921-934. PubMed ID: 33228395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.
    Millwood IY; Bennett DA; Holmes MV; Boxall R; Guo Y; Bian Z; Yang L; Sansome S; Chen Y; Du H; Yu C; Hacker A; Reilly DF; Tan Y; Hill MR; Chen J; Peto R; Shen H; Collins R; Clarke R; Li L; Walters RG; Chen Z;
    JAMA Cardiol; 2018 Jan; 3(1):34-43. PubMed ID: 29141072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians.
    Nair AK; Piaggi P; McLean NA; Kaur M; Kobes S; Knowler WC; Bogardus C; Hanson RL; Baier LJ
    Diabetologia; 2016 Mar; 59(3):481-91. PubMed ID: 26670163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Cholesteryl Ester Transfer Protein TaqIB Polymorphism with the Composite Ischemic Cardiovascular Disease Risk and HDL-C Concentrations: A Meta-Analysis.
    Guo SX; Yao MH; Ding YS; Zhang JY; Yan YZ; Liu JM; Zhang M; Rui DS; Niu Q; He J; Guo H; Ma RL
    Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27608031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
    Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
    DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S; Schmitz C; Stampfer MJ; Sacks F; Hennekens CH; Lindpaintner K; Ridker PM
    Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W; Guerin M; Nicaud V; Dachet C; Luc G; Arveiler D; Ruidavets JB; Evans A; Kee F; Morrison C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population.
    Wang J; Wang LJ; Zhong Y; Gu P; Shao JQ; Jiang SS; Gong JB
    Lipids Health Dis; 2013 Nov; 12():176. PubMed ID: 24283500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels.
    Isaacs A; Aulchenko YS; Hofman A; Sijbrands EJ; Sayed-Tabatabaei FA; Klungel OH; Maitland-van der Zee AH; Stricker BH; Oostra BA; Witteman JC; van Duijn CM
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2680-7. PubMed ID: 17440012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl ester transfer protein (CETP) genetic variation and early onset of non-fatal myocardial infarction.
    Meiner V; Friedlander Y; Milo H; Sharon N; Ben-Avi L; Shpitzen S; Leitersdorf E; Siscovick DS; Schwartz SM
    Ann Hum Genet; 2008 Nov; 72(Pt 6):732-41. PubMed ID: 18637884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of common SNPs and haplotypes in CETP gene with HDL cholesterol levels in Latvian population.
    Radovica I; Fridmanis D; Vaivade I; Nikitina-Zake L; Klovins J
    PLoS One; 2013; 8(5):e64191. PubMed ID: 23675527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population.
    Nordestgaard LT; Christoffersen M; Lauridsen BK; Afzal S; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    JAMA Cardiol; 2022 Jan; 7(1):55-64. PubMed ID: 34613338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven functional polymorphisms in the CETP gene and myocardial infarction risk: a meta-analysis and meta-regression.
    Wang Q; Zhou SB; Wang LJ; Lei MM; Wang Y; Miao C; Jin YZ
    PLoS One; 2014; 9(2):e88118. PubMed ID: 24533069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.